| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.029 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |